SPG11 and hereditary spastic paraplegia: Here, we report a Chinese HSP-TCC non-consanguineous family whose affected family members possess two compound heterozygous mutations in SPG11. These results implicate a need for wider screening of SPG11 mutations in ARHSP-TCC patients.